Advances in stroke 2017

Julie Bernhardt; Richard D. Zorowitz; Kyra J. Becker; Emanuela Keller; Gustavo Saposnik; Daniel Strbian; Martin Dichgans; Daniel Woo; Mathew Reeves; Amanda Thrift; Chelsea S. Kidwell; Jean Marc Olivot; Mayank Goyal; Laurent Pierot; Derrick A. Bennett; George Howard; Gary A. Ford; Larry B. Goldstein; Anna M. Planas; Midori A. Yenari; Steven M. Greenberg; Leonardo Pantoni; Sepideh Amin-Hanjani; Michael Tymianski

doi:10.1161/STROKEAHA.118.021380

Advances in stroke 2017

Julie Bernhardt, Richard D. Zorowitz, Kyra J. Becker, Emanuela Keller, Gustavo Saposnik, Daniel Strbian, Martin Dichgans, Daniel Woo, Mathew Reeves, Amanda Thrift, Chelsea S. Kidwell, Jean Marc Olivot, Mayank Goyal, Laurent Pierot, Derrick A. Bennett, George Howard, Gary A. Ford, Larry B. Goldstein, Anna M. Planas, Midori A. YenariSteven M. Greenberg, Leonardo Pantoni, Sepideh Amin-Hanjani, Michael Tymianski

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Original language	English (US)
Pages (from-to)	E174-E199
Journal	Stroke
Volume	49
Issue number	5
DOIs	https://doi.org/10.1161/STROKEAHA.118.021380
State	Published - 2018

Keywords

Alleles
Cognition
Gait
Quality of life
White matter

ASJC Scopus subject areas

Clinical Neurology
Cardiology and Cardiovascular Medicine
Advanced and Specialized Nursing

Access to Document

10.1161/STROKEAHA.118.021380

Cite this

Bernhardt, J., Zorowitz, R. D., Becker, K. J., Keller, E., Saposnik, G., Strbian, D., Dichgans, M., Woo, D., Reeves, M., Thrift, A., Kidwell, C. S., Olivot, J. M., Goyal, M., Pierot, L., Bennett, D. A., Howard, G., Ford, G. A., Goldstein, L. B., Planas, A. M., ... Tymianski, M. (2018). Advances in stroke 2017. Stroke, 49(5), E174-E199. https://doi.org/10.1161/STROKEAHA.118.021380

Bernhardt, J, Zorowitz, RD, Becker, KJ, Keller, E, Saposnik, G, Strbian, D, Dichgans, M, Woo, D, Reeves, M, Thrift, A, Kidwell, CS, Olivot, JM, Goyal, M, Pierot, L, Bennett, DA, Howard, G, Ford, GA, Goldstein, LB, Planas, AM, Yenari, MA, Greenberg, SM, Pantoni, L, Amin-Hanjani, S & Tymianski, M 2018, 'Advances in stroke 2017', Stroke, vol. 49, no. 5, pp. E174-E199. https://doi.org/10.1161/STROKEAHA.118.021380

@article{90ba76dc480d4008b816c863ac78483e,

title = "Advances in stroke 2017",

keywords = "Alleles, Cognition, Gait, Quality of life, White matter",

author = "Julie Bernhardt and Zorowitz, {Richard D.} and Becker, {Kyra J.} and Emanuela Keller and Gustavo Saposnik and Daniel Strbian and Martin Dichgans and Daniel Woo and Mathew Reeves and Amanda Thrift and Kidwell, {Chelsea S.} and Olivot, {Jean Marc} and Mayank Goyal and Laurent Pierot and Bennett, {Derrick A.} and George Howard and Ford, {Gary A.} and Goldstein, {Larry B.} and Planas, {Anna M.} and Yenari, {Midori A.} and Greenberg, {Steven M.} and Leonardo Pantoni and Sepideh Amin-Hanjani and Michael Tymianski",

note = "Funding Information: Dr Thrift receives funding from the National Health & Medical Research Council of Australia (GNT1042600). G. Howard receives funding from the National Institutes of Health (NIH). Dr Yenari receives funding from the Department of Veterans Affairs Merit Grant. Funding Information: Dr Bernhardt served as an Advisor on the DART Neuroscience trial (Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors) that was discontinued, attended the 2017 investigator meeting in Sydney, Australia, and established and cochaired the Stroke Recovery and Rehabilitation Roundtable. Dr Olivot received speaker fees from Bristol Myers Squibb and Pfizer, and serves as a consultant for Servier, Medtronic, and Astra Zeneca. Dr Pierot serves as a consultant for Balt, Microvention, and Penumbra. Dr Goyal serves as a consultant for Microvention, Stryker, and Medtronic Neurovascular, and as coprincipal investigator for ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) and SWIFT PRIME (Solitaire With the Intention For Thrombectomy as Primary Endovascular Treatment) trials. Medtronic provided a grant to University of Calgary toward the HERMES (Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials) collaboration. Stryker provided a research grant to the University toward the UNMASK EVT study (Decision Making Under Uncertainty in the Management of Acute Stroke With Endovascular Thrombectomy: Applying Principles From Neuroeconomics). G.A. Ford reports speaking fees from Medtronic. Dr Amin-Hanjani reports research support from Edge Therapeutics for the NEWTON trial (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage) and from the National Institutes of Health (no compensation). The other authors report no conflicts.",

year = "2018",

doi = "10.1161/STROKEAHA.118.021380",

language = "English (US)",

volume = "49",

pages = "E174--E199",

journal = "Stroke",

issn = "0039-2499",

publisher = "Wolters Kluwer Health",

number = "5",

}

TY - JOUR

T1 - Advances in stroke 2017

AU - Bernhardt, Julie

AU - Zorowitz, Richard D.

AU - Becker, Kyra J.

AU - Keller, Emanuela

AU - Saposnik, Gustavo

AU - Strbian, Daniel

AU - Dichgans, Martin

AU - Woo, Daniel

AU - Reeves, Mathew

AU - Thrift, Amanda

AU - Kidwell, Chelsea S.

AU - Olivot, Jean Marc

AU - Goyal, Mayank

AU - Pierot, Laurent

AU - Bennett, Derrick A.

AU - Howard, George

AU - Ford, Gary A.

AU - Goldstein, Larry B.

AU - Planas, Anna M.

AU - Yenari, Midori A.

AU - Greenberg, Steven M.

AU - Pantoni, Leonardo

AU - Amin-Hanjani, Sepideh

AU - Tymianski, Michael

N1 - Funding Information: Dr Thrift receives funding from the National Health & Medical Research Council of Australia (GNT1042600). G. Howard receives funding from the National Institutes of Health (NIH). Dr Yenari receives funding from the Department of Veterans Affairs Merit Grant. Funding Information: Dr Bernhardt served as an Advisor on the DART Neuroscience trial (Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors) that was discontinued, attended the 2017 investigator meeting in Sydney, Australia, and established and cochaired the Stroke Recovery and Rehabilitation Roundtable. Dr Olivot received speaker fees from Bristol Myers Squibb and Pfizer, and serves as a consultant for Servier, Medtronic, and Astra Zeneca. Dr Pierot serves as a consultant for Balt, Microvention, and Penumbra. Dr Goyal serves as a consultant for Microvention, Stryker, and Medtronic Neurovascular, and as coprincipal investigator for ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) and SWIFT PRIME (Solitaire With the Intention For Thrombectomy as Primary Endovascular Treatment) trials. Medtronic provided a grant to University of Calgary toward the HERMES (Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials) collaboration. Stryker provided a research grant to the University toward the UNMASK EVT study (Decision Making Under Uncertainty in the Management of Acute Stroke With Endovascular Thrombectomy: Applying Principles From Neuroeconomics). G.A. Ford reports speaking fees from Medtronic. Dr Amin-Hanjani reports research support from Edge Therapeutics for the NEWTON trial (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage) and from the National Institutes of Health (no compensation). The other authors report no conflicts.

PY - 2018

Y1 - 2018

KW - Alleles

KW - Cognition

KW - Gait

KW - Quality of life

KW - White matter

UR - http://www.scopus.com/inward/record.url?scp=85056364394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056364394&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.118.021380

DO - 10.1161/STROKEAHA.118.021380

M3 - Article

C2 - 29669874

AN - SCOPUS:85056364394

SN - 0039-2499

VL - 49

SP - E174-E199

JO - Stroke

JF - Stroke

IS - 5

ER -

Advances in stroke 2017

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this